Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,400 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 5 February 2020) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download: 

(PDF, 3MB, 197 pages)

 

Export 2449 results:
Author Title Type [ Year(Asc)]
2019
H. J. Forbes, Wong, A. Y. S., Morton, C., Bhaskaran, K., Smeeth, L., Richards, M., Schmidt, S. A. J., Langan, S. M., and Warren-Gash, C., “Partner Bereavement and Detection of Dementia: A UK-Based Cohort Study Using Routine Health Data”, J Alzheimers Dis, 2019.
A. Y. S. Wong, Froslev, T., Forbes, H. J., Kjaersgaard, A., Mulick, A., Mansfield, K., Silverwood, R. J., Sorensen, H. T., Smeeth, L., Schmidt, S. A. J., and Langan, S. M., “Partner bereavement and risk of psoriasis and atopic eczema: cohort studies in the United Kingdom and Denmark”, Br J Dermatol, 2019.
S. Lay-Flurrie, Mathieu, E., Bankhead, C., Nicholson, B. D., Perera-Salazar, R., Holt, T., Hobbs, F. D. R., and Salisbury, C., “Patient consultation rate and clinical and NHS outcomes: a cross-sectional analysis of English primary care data from 2.7 million patients in 238 practices”, BMC Health Serv Res, vol. 19, p. 219, 2019.
Y. Chen, Farooq, S., Edwards, J., Chew-Graham, C. A., Shiers, D., Frisher, M., Hayward, R., Sumathipala, A., and Jordan, K. P., “Patterns of symptoms before a diagnosis of first episode psychosis: a latent class analysis of UK primary care electronic health records”, BMC Med, vol. 17, p. 227, 2019.
J. Morley, Moayyeri, A., Ali, L., Taylor, A., Feudjo-Tepie, M., Hamilton, L., and Bayly, J., “Persistence and compliance with osteoporosis therapies among postmenopausal women in the UK Clinical Practice Research Datalink”, Osteoporos Int, 2019.
J. S. Floyd, Bloch, K. M., Brody, J. A., Maroteau, C., Siddiqui, M. K., Gregory, R., Carr, D. F., Molokhia, M., Liu, X., Bis, J. C., Ahmed, A., Liu, X., Hallberg, P., Yue, Q. Y., Magnusson, P. K. E., Brisson, D., Wiggins, K. L., Morrison, A. C., Khoury, E., McKeigue, P., Stricker, B. H., Lapeyre-Mestre, M., Heckbert, S. R., Gallagher, A. M., Chinoy, H., Gibbs, R. A., Bondon-Guitton, E., Tracy, R., Boerwinkle, E., Gaudet, D., Conforti, A., Van Staa, T., Sitlani, C. M., Rice, K. M., van der Zee, A. H. Maitlan, Wadelius, M., Morris, A. P., Pirmohamed, M., Palmer, C. A. N., Psaty, B. M., and Alfirevic, A., “Pharmacogenomics of statin-related myopathy: Meta-analysis of rare variants from whole-exome sequencing”, PLoS One, vol. 14, p. e0218115, 2019.
X. Sun, Douiri, A., and Gulliford, M., “Pneumonia incidence trends in UK primary care from 2002 to 2017: population-based cohort study”, Epidemiol Infect, vol. 147, p. e263, 2019.
R. Denholm, Morris, R., and Payne, R., “Polypharmacy patterns in the last year of life in patients with dementia”, Eur J Clin Pharmacol, 2019.
N. R. Hill, Ayoubkhani, D., McEwan, P., Sugrue, D. M., Farooqui, U., Lister, S., Lumley, M., Bakhai, A., Cohen, A. T., O'Neill, M., Clifton, D., and Gordon, J., “Predicting atrial fibrillation in primary care using machine learning”, PLoS One, vol. 14, p. e0224582, 2019.
C. I. Bloom, Ricciardi, F., Smeeth, L., Stone, P., and Quint, J. K., “Predicting COPD 1-year mortality using prognostic predictors routinely measured in primary care”, BMC Med, vol. 17, p. 73, 2019.
S. F. Weng, Vaz, L., Qureshi, N., and Kai, J., “Prediction of premature all-cause mortality: A prospective general population cohort study comparing machine-learning and standard epidemiological approaches”, PLoS One, vol. 14, p. e0214365, 2019.
J. Watson, Salisbury, C., Banks, J., Whiting, P., and Hamilton, W., “Predictive value of inflammatory markers for cancer diagnosis in primary care: a prospective cohort study using electronic health records”, Br J Cancer, 2019.
S. Venkatesan, Jorgensen, M. E., Manning, H. J., Andersson, C., Mozid, A. M., Coburn, M., Moonesinghe, S. R., Foex, P., Mythen, M., Grocott, M. P. W., Hardman, J. G., Myles, P. R., and Sanders, R. D., “Preoperative chronic beta-blocker prescription in elderly patients as a risk factor for postoperative mortality stratified by preoperative blood pressure: a cohort study”, Br J Anaesth, 2019.
T. Newlove-Delgado, Hamilton, W., Ford, T. J., Stein, K., and Ukoumunne, O. C., “Prescribing for young people with attention deficit hyperactivity disorder in UK primary care: analysis of data from the Clinical Practice Research Datalink”, Atten Defic Hyperact Disord, 2019.
J. Macleod, Steer, C., Tilling, K., Cornish, R., Marsden, J., Millar, T., Strang, J., and Hickman, M., “Prescription of benzodiazepines, z-drugs, and gabapentinoids and mortality risk in people receiving opioid agonist treatment: Observational study based on the UK Clinical Practice Research Datalink and Office for National Statistics death records”, PLoS Med, vol. 16, p. e1002965, 2019.
M. J. Carr, Ashcroft, D. M., White, P. D., Kapur, N., and Webb, R. T., “Prevalence of comorbid mental and physical illnesses and risks for self-harm and premature death among primary care patients diagnosed with fatigue syndromes”, Psychol Med, pp. 1-8, 2019.
D. Lautsch, Wang, T., Yang, L., and Rajpathak, S. N., “Prevalence of Established Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in the UK”, Diabetes Ther, 2019.
K. M. Abel, Hope, H., Swift, E., Parisi, R., Ashcroft, D. M., Kosidou, K., Osam, C. S., Dalman, C., and Pierce, M., “Prevalence of maternal mental illness among children and adolescents in the UK between 2005 and 2017: a national retrospective cohort analysis”, Lancet Public Health, vol. 4, pp. e291-e300, 2019.
C. E. Lefebvre, Filion, K. B., Reynier, P., Platt, R. W., and Zappitelli, M., “Primary Care Prescriptions of Potentially Nephrotoxic Medications in Children with CKD”, Clin J Am Soc Nephrol, 2019.
Y. Qian and Jick, S., “Proton pump inhibitor use and myocardial infarction: a nested study in the UK Clinical Practice Research Datalink”, Epidemiology, 2019.
V. W. Zhong, Juhaeri, J., Cole, S. R., Shay, C. M., Gordon-Larsen, P., Kontopantelis, E., and Mayer-Davis, E. J., “Proximal HbA1C Level and First Hypoglycemia Hospitalization in Adults with Incident Type 2 Diabetes”, J Clin Endocrinol Metab, 2019.
H. P. Booth, Gallagher, A. M., Mullett, D., Carty, L., Padmanabhan, S., Myles, P. R., Welburn, S. J., Hoghton, M., Rafi, I., and Valentine, J., “Quality improvement of prescribing safety: a pilot study in primary care using UK electronic health records”, Br J Gen Pract, 2019.
A. Gayle, Tebboth, A., Pang, M., Guelfucci, F., Argoubi, R., Sherman, S., and Mak, V., “Real-life prescribing of asthmatic treatments in UK general practice over time using 2014 BTS/SIGN steps”, NPJ Prim Care Respir Med, vol. 29, p. 25, 2019.
C. Linde, Bakhai, A., Furuland, H., Evans, M., McEwan, P., Ayoubkhani, D., and Qin, L., “Real-World Associations of Renin-Angiotensin-Aldosterone System Inhibitor Dose, Hyperkalemia, and Adverse Clinical Outcomes in a Cohort of Patients With New-Onset Chronic Kidney Disease or Heart Failure in the United Kingdom”, J Am Heart Assoc, vol. 8, p. e012655, 2019.
E. A. Shephard, Parkinson, M. A., and Hamilton, W. T., “Recognising laryngeal cancer in primary care: a large case-control study using electronic records”, Br J Gen Pract, vol. 69, pp. e127-e133, 2019.
X. Sun and Gulliford, M. C., “Reducing antibiotic prescribing in primary care in England from 2014 to 2017: population-based cohort study”, BMJ Open, vol. 9, p. e023989, 2019.
A. Rao, Kim, D., Darzi, A., Majeed, A., Aylin, P., and Bottle, A., “Regional variations in trajectories of long-term readmission rates among patients in England with heart failure”, BMC Cardiovasc Disord, vol. 19, p. 86, 2019.
Y. Li, Molter, A., White, A., Welfare, W., Palin, V., Belmonte, M., Ashcroft, D. M., Sperrin, M., and van Staa, T. P., “Relationship between prescribing of antibiotics and other medicines in primary care: a cross-sectional study”, Br J Gen Pract, vol. 69, pp. e42-e51, 2019.
S. V. Ramagopalan, Stamp, E., Sammon, C. J., Besford, M., Carroll, R., Mehmud, F., and Alikhan, R., “Renal function and oral anticoagulant treatment of incident non-valvular atrial fibrillation: a retrospective study”, Future Cardiol, 2019.
S. Weir, Kuo, T. C., Samnaliev, M., Tierney, T. S., Manca, A., Taylor, R. S., Bruce, J., Eldabe, S., and Cumming, D., “Reoperation following lumbar spinal surgery: costs and outcomes in a UK population cohort study using the Clinical Practice Research Datalink (CPRD) and Hospital Episode Statistics (HES)”, Eur Spine J, 2019.
T. Newlove-Delgado, Ford, T. J., Hamilton, W., Janssens, A., Stein, K., and Ukoumunne, O. C., “Resumption of attention-deficit hyperactivity disorder medication in early adulthood: findings from a UK primary care prescribing study”, Eur Child Adolesc Psychiatry, 2019.
A. Uijl, Koudstaal, S., Direk, K., Denaxas, S., Groenwold, R. H. H., Banerjee, A., Hoes, A. W., Hemingway, H., and Asselbergs, F. W., “Risk factors for incident heart failure in age- and sex-specific strata: a population-based cohort using linked electronic health records”, Eur J Heart Fail, 2019.
J. Bedson, Chen, Y., Ashworth, J., Hayward, R. A., Dunn, K. M., and Jordan, K. P., “Risk of adverse events in patients prescribed long-term opioids: A cohort study in the UK Clinical Practice Research Datalink”, Eur J Pain, 2019.
S. E. Bromley, Matthews, A., Smeeth, L., Stanway, S., and Bhaskaran, K., “Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK”, J Cancer Surviv, vol. 13, pp. 632-640, 2019.
J. B. Wetmore, Yan, H., Horne, L., Peng, Y., and Gilbertson, D. T., “Risk of hyperkalemia from renin-angiotensin-aldosterone system inhibitors and factors associated with treatment discontinuities in a real-world population”, Nephrol Dial Transplant, 2019.
E. Williamson, Denaxas, S., Morris, S., Clarke, C. S., Thomas, M., Evans, H., Direk, K., Gonzalez-Izquierdo, A., Little, P., Lund, V., Blackshaw, H., Schilder, A., Philpott, C., Hopkins, C., and Carpenter, J., “Risk of mortality and cardiovascular events following macrolide prescription in chronic rhinosinusitis patients: a cohort study using linked primary care electronic health records”, Rhinology, 2019.
R. Alikhan, Lefevre, C., Menown, I., Lister, S., Bird, A., You, M., Evans, D., and Sammon, C., “Risk of Recurrent Bleeding Events in Nonvalvular Atrial Fibrillation Treated with Vitamin K Antagonists: A Clinical Practice Research Datalink Study”, TH Open, vol. 3, pp. e316-e324, 2019.
A. Adiamah, Ban, L., West, J., and Humes, D. J., “The risk of venous thromboembolism after surgery for esophagogastric malignancy and the impact of chemotherapy: a population-based cohort study”, Dis Esophagus, 2019.
F. Zaccardi, Husemoen, L. L. Nystrup, Thorsted, B. L., Webb, D. R., Paul, S. K., Davies, M. J., and Khunti, K., “Selectivity of beta-blockers, cardiovascular and all-cause mortality in people with hypoglycaemia: An observational study”, Nutr Metab Cardiovasc Dis, vol. 29, pp. 481-488, 2019.
C. Linde, Qin, L., Bakhai, A., Furuland, H., Evans, M., Ayoubkhani, D., Palaka, E., Bennett, H., and McEwan, P., “Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK”, ESC Heart Fail, 2019.
M. Rafiq, Hayward, A., Warren-Gash, C., Denaxas, S., Gonzalez-Izquierdo, A., Lyratzopoulos, G., and Thomas, S., “Socioeconomic deprivation and regional variation in Hodgkin's lymphoma incidence in the UK: a population-based cohort study of 10 million individuals”, BMJ Open, vol. 9, p. e029228, 2019.
M. Weldegiorgis, Smith, M., Herrington, W. G., Bankhead, C., and Woodward, M., “Socioeconomic disadvantage and the risk of advanced chronic kidney disease: results from a cohort study with 1.4 million participants”, Nephrology Dialysis Transplantation, 2019.
M. S. Chan, van den Hout, A., Pujades-Rodriguez, M., Jones, M. M., Matthews, F. E., Jagger, C., Raine, R., and Bajekal, M., “Socio-economic inequalities in life expectancy of older adults with and without multimorbidity: a record linkage study of 1.1 million people in England”, Int J Epidemiol, 2019.
G. J. Lefeber, Koek, H. L., Souverein, P. C., Bouvy, M. L., de Boer, A., and Knol, W., “Statins After Myocardial Infarction in the Oldest: A Cohort Study in the Clinical Practice Research Datalink Database”, J Am Geriatr Soc, 2019.
N. Frey, Bodmer, M., Bircher, A., Jick, S. S., Meier, C. R., and Spoendlin, J., “Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study”, Drug Saf, vol. 42, pp. 55-66, 2019.
J. Fortuny, Gilsenan, A., Cainzos-Achirica, M., Cantero, O. F., Flynn, R. W. V., Garcia-Rodriguez, L., Kollhorst, B., Karlsson, P., Linner, L., MacDonald, T. M., Plana, E., Ruigomez, A., Schink, T., Ziemiecki, R., and Andrews, E. B., “Study Design and Cohort Comparability in a Study of Major Cardiovascular Events in New Users of Prucalopride Versus Polyethylene Glycol 3350”, Drug Saf, 2019.
N. A. Stohler, Reinau, D., Jick, S. S., Bodmer, D., and Meier, C. R., “A study on the epidemiology of tinnitus in the United Kingdom”, Clin Epidemiol, vol. 11, pp. 855-871, 2019.
R. K. Akyea, Kai, J., Qureshi, N., Iyen, B., and Weng, S. F., “Sub-optimal cholesterol response to initiation of statins and future risk of cardiovascular disease”, Heart, 2019.
A. Banerjee, Allan, V., Denaxas, S., Shah, A., Kotecha, D., Lambiase, P. D., Jacob, J., Lund, L. H., and Hemingway, H., “Subtypes of atrial fibrillation with concomitant valvular heart disease derived from electronic health records: phenotypes, population prevalence, trends and prognosis”, Europace, 2019.
K. B. Filion, Douros, A., Azoulay, L., Yin, H., Yu, O. H., and Suissa, S., “Sulfonylureas as initial treatment for type 2 diabetes and the risk of adverse cardiovascular events: A population-based cohort study”, Br J Clin Pharmacol, 2019.
[Page last reviewed 5 February 2020]